期刊文献+

艰难梭菌感染的流行状况及耐药机制研究进展 被引量:2

Advances of epidemiology and resistance mechanism of Clostridium difficile infection
下载PDF
导出
摘要 近年来艰难梭菌感染(CDI)的流行状况发生了巨大变化,随着其感染率的增加及病情的加剧,CDI已成为一个全球性的健康问题。CDI曾在北美和欧洲数次暴发流行,同样艰难梭菌也已成为亚洲地区重要的院内感染病原体,但目前国内对CDI的认识和临床感染监控还不够。了解CDI的流行状况和艰难梭菌耐药情况,可以为临床预防及治疗CDI提供依据。本文将就CDI的流行状况及耐药机制的研究进展进行综述。 In recent years, with the dramatic changes in the epidemiology of Clostridium difficile infection (CDI) as well as increases in incidence and severity of the disease, CDI has become a global public health challenge. There have been several outbreaks of CDI in North America and Europe and Clostridium difficile has also become an important pathogenic cause of nosocomial infection in Asia. However, the awareness and surveillance of CDI still remain poor in China. A better knowledge of the epidemiology of CDI and antimicrobial resistance of Clostridium difficile can provide the basis for the prevention and treatment of CDI. This paper reviews the epidemiology and research progresses of resistance mechanism of CDI.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第6期919-923,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市科委基础重点项目(12JC1406100)~~
关键词 艰难梭菌 流行病学 耐药机制 毒力因子 Clostridium difficile epidemiology resistance mechanisms virulence factors
  • 相关文献

参考文献23

  • 1Bassetti M,Villa G,Pecori D,et al.Epidemiology,diagnosis andtreatment of Clostridium difficile infection [J].Expert Rev AntiInfect Ther,2012,10(12):1405-1423.
  • 2Heinlen L,Ballard JD.Clostridium difficile infection [J].Am JMed Sci,2010,340(3):247-252.
  • 3Lynch T,Chong P,Zhang J,et al.Characterization of a stable,metronidazole-resistant Clostridium difficile clinical isolate[J].PlosOne,2013,8(1):e53757.
  • 4Garg S,Mirza YR,Girotra M,et al.Epidemiology of Clostridium difficile-associated disease(CDAD):a shift from hospital-acquired infection to long-term care facility-based infection[J].Dig Dis Sci,2013,58(12):3407-3412.
  • 5Collins DA,Hawkey PM,Riley TV.Epidemiology of Clostridiumdifficile infection in Asia [J].Antimicrob Resist Infect Control,2013,2(1):21.
  • 6Lessa FC,Gould CV,McDonald LC.Current status of Clostridiumdifficile infection epidemiology [J].Clin Infect Dis,2012,55(suppl2):S65-S70.
  • 7Jin K,Wang S,Huang Z,et al.Clostridium difficile infections inChina[J].J Biomed Res,2010,24(6):411-416.
  • 8Silva Junior M.Recent changes in Clostridium difficile infection[J].Einstein(Sao Paulo),2012,10(1):105-109.
  • 9Vedantam G,Clark A,Chu M,et al.Clostridium difficile infection:toxins and non-toxin virulence factors,and their contributions todisease establishment and host response [J].Gut microbes,2012,3(2);121-134.
  • 10O'Connor JR,Johnson S,Gerding DN.Clostridium difficile infectioncaused by the epidemic BI/NAP1/027 strain[J].Gastroenterology,2009,136(6):1913-1924.

二级参考文献41

  • 1Songer JG. The emergence of Clostridium difficile as a pathogen of food animals [J]. Animal Health Res Rev, 2005,5: 321-326.
  • 2Kuijper EJ, de Weerdt J, Kato H,et al. Nosocomial outbreak of Clostridium difficile-assoeiated diarrhoea due to a elindamycin-resistant enterotoxin A-negative strain [J]. Eur J Clin Microbiol Infect Dis, 2001, 20 (8): 528-534.
  • 3Bartlett JG. Antibiotic-associated diarrhea[J]. N Engl J Med, 2002, 346(5): 334-339.
  • 4Poxton IR,McCoubrey J, Blair J. The pathogenicity of Clostridium difficile [J]. Clin Mierobiol Infect, 2001, 7: 421-427.
  • 5al-Barrak A, Embil J, Dyek B, et al. An outbreak of toxin A negative, toxin B positive Clostridium difficileassociated diarrhea in a Canadian tertiary-care hospital[J]. Can Commun Dis Rep,1999,25(7):65-69.
  • 6Martin H, Willey B, Low DE, et al. Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006 [J]. J Clic Microbiol,2008,46(9) : 2999-3004.
  • 7Kim H, Riley TV, Kim M,et al. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis [J]. J Clin Microbiol,2008,46(3) :1116.
  • 8Huang H, Wu S, Wang M, et al. Clostridium difficile infections in Shanghai hospital: antimicrobial resistance, toxin profiles and ribotyping [J]. Int J Antimicrob Agents, 2008,12 : 19.
  • 9Van den Berg RJ, Claas ECJ,Oyib DH, et al. Characterization of Toxin A Negative, Toxin B-Positive Clostridium difficile Isolates from Outbreaks in Different Countries by Amplified Fragment Length Polymorphism and PCR Ribotyping [J]. J Clin Microbiol, 2004, 42 (3): 1035-1041.
  • 10Aspevall O, Lundberg A, Burman LG, et al. Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital [J]. Antimicrob Agents Chemother, 2006,50 (5) :1890.

共引文献29

同被引文献5

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部